Enhancing Immune Checkpoint Inhibitor Therapy in Kidney Cancer
Technical Report,30 Sep 2016,29 Sep 2017
University of Texas Southwestern Medical Center Dallas United States
Pagination or Media Count:
The purpose of this work is to develop strategies to enhance immune checkpoint inhibition in kidney cancer. The work is designed to test different strategies to induce or enhance the abscopal in a kidney cancer model by combining ablative techniques or TLR agonists with PD1 inhibitors. Funds were transferred to UT Southwestern mid 2017. The PI is in the process of getting IACUCACURO approval for the proposed animal studies.
- Medicine and Medical Research